Clinical Trials
710 trialsMK-4280A-007
Merck Sharp & Dohme LLC
Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer
Emory University
NEST-1
Weill Medical College of Cornell University
SafeHeal Anastomosis Feasibility Evaluation (SAFE)-2023 Study
SafeHeal Inc
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
Alliance for Clinical Trials in Oncology
SCORE
UNC Lineberger Comprehensive Cancer Center
ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension
Massachusetts General Hospital
Head to Head Pilot Trial of Mailed Cologuard to Mailed FIT
University of California, San Diego
A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study
Genentech, Inc.
LEAP-005
Merck Sharp & Dohme LLC
PI Pembro in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal Cancer
University of Wisconsin, Madison
NAUTICALCRC
Pierre Fabre Medicament
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps
National Cancer Institute (NCI)
CHALLENGE
Canadian Cancer Trials Group
ANICCA
University of Birmingham
AXMUS-C
Imperial College London
AH-HA
Wake Forest University Health Sciences
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma
National Cancer Institute (NCI)
HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics
City of Hope Medical Center
Social Media and Cancer Screening Information
University of Utah
ALASCCA
Karolinska Institutet
Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Dana-Farber Cancer Institute
VB-111 in Combination With Nivolumab in People With Metastatic Colorectal Cancer (mCRC)
National Institutes of Health Clinical Center (CC)
ARETHUSA
IFOM ETS - The AIRC Institute of Molecular Oncology
FOLFIRINOX-R
Institut du Cancer de Montpellier - Val d'Aurelle
Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers
Seagen Inc.
Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers
National Institutes of Health Clinical Center (CC)
Precision-Based Magnesium Trial
Vanderbilt University Medical Center
A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer
Inspirna, Inc.
Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery
M.D. Anderson Cancer Center
Efficacy and Safety of Tislelizumab (BGB-A317) as Neo-Adjuvant Treatment in Participants With Colorectal Cancer
BeOne Medicines
RECITE
Amgen
PCSNaP
Abramson Cancer Center at Penn Medicine
TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study
Roswell Park Cancer Institute
A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma
Memorial Sloan Kettering Cancer Center
MK-7902-017
Merck Sharp & Dohme LLC
Screen to Save 2: Rural Cancer Screening Educational Intervention
Dartmouth-Hitchcock Medical Center
Optimization of Adaptive Text Messages for Cancer Survivors (OATS II)
University of California, San Francisco
ALTAIR
National Cancer Center Hospital East
PeLear CCC
University of North Carolina, Chapel Hill
Implementing a Multilevel Intervention to Accelerate Colorectal Cancer Screening and Follow-up
Milton S. Hershey Medical Center
DESTINY-CRC02
Daiichi Sankyo
KANSURVIVE
University of Kansas Medical Center
NIPAVect
Emory University
CAPSTAN CRC
Pierre Fabre Medicament
E-PROOF
Ohio State University Comprehensive Cancer Center
A Smartphone-Based Intervention to Improve Colorectal Cancer Screening in African American Men
ISA Associates, Inc.
Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases
University of California, San Francisco
PREEMPT CRC
Freenome Holdings Inc.